Table 1.
Comparison of Baseline Characteristics between Injectable Opioid Shortage and Control Cohorts.
| Characteristic | Shortage (n = 50) | Control (n = 50) | P-value |
|---|---|---|---|
| Female | 23 (46.0) | 24 (48.0) | .841 |
| Age (years) | 54.0 ± 15.9 | 59.1 ± 15.6 | .106 |
| Height (cm) | 168.8 ± 11.6 | 170.7 ± 10.6 | .395 |
| Weight (kg) | 79.2 ± 22.4 | 97.1 ± 39.1 | .006 |
| BMI (kg/m2) | 27.5 ± 6.6 | 33.1 ± 12.1 | .006 |
| ARDS diagnosis | 1 (2.0) | 6 (12.0) | .112 † |
| Chronic opioid use >30 OME/day | 9 (18.0) | 2 (4.0) | .025 |
| Active drug abuse (heroin, cocaine, recreational opioids) | 4 (8.0) | 3 (6.0) | 1.000 † |
| APACHE II score | 28.0 [22.0-31.0] | 25.0 [23.0-27.0] | .220 |
| Charlson comorbidity index | 5.0 [4.5-6.0] | 5.5 [2.0-9.0] | .972 |
Note. Nominal data are presented as number (percentage). Continuous data are presented as mean ± standard deviation (SD) if parametric or median [interquartile range (IQR)] if non-parametric. BMI = body mass index; ARDS = acute respiratory distress syndrome, OME = oral morphine equivalents.
†
Fisher’s exact test.